P. Shah

发表

Procalcitonin, a new diagnostic and prognostic marker for severe infections.

B. Al-Nawas, P. Shah, B. Al‐Nawas, 1998, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Ventilator-associated pneumonia—Understanding epidemiology and pathogenesis to guide prevention and empiric therapy

P. Francioli, A. Torres, J. Santos, 1997 .

Prospective randomized study to compare imipenem 1.5 grams per day vs. 3.0 grams per day in infections of granulocytopenic patients.

D. Hoelzer, A. Böhme, P. Shah, 1998, Journal of Infection.

Intracellular Antimycobacterial Activity of Ciprofloxacin and Ofloxacin in Mycobacterium Fortuitum Infected Human Polymorphonuclear Leucocytes

P. Nziramasanga, P. Shah, W. Stille, 1995 .

Procalcitonin, C-reactive protein and APACHE II score for risk evaluation in patients with severe pneumonia.

B. Al-Nawas, F. Krummenauer, P. Shah, 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Incidence of multi-resistance in gram-negative aerobes from intensive care units of 10 German hospitals.

P. Shah, F. Kahan, R. Asanger, 1991, Scandinavian journal of infectious diseases. Supplementum.

Control of intracellular growth of Mycobacterium fortuitum by human monocytes in vitro.

P. Nziramasanga, P. Shah, W. Stille, 1993, Journal of chemotherapy.

Comment on: Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy.

P. Shah, 2005, The Journal of antimicrobial chemotherapy.

Gyrase-inhibitors impair caffeine elimination in man.

A. Staib, S. Harder, P. Shah, 1987, Methods and findings in experimental and clinical pharmacology.

4-quinolones inhibit biotransformation of caffeine

A. Staib, S. Harder, P. Shah, 2004, European Journal of Clinical Pharmacology.

Procalcitonin in diagnosis of severe infections.

B. Al-Nawas, P. Shah, I. Krammer, 1996, European journal of medical research.

Procalcitonin in acute malaria.

B. Al-Nawas, P. Shah, B. Al‐Nawas, 1997, European journal of medical research.

Ertapenem, the first of a new group of carbapenems.

R. Isaacs, P. Shah, 2003, The Journal of antimicrobial chemotherapy.

Calculated parenteral initial therapy of bacterial infections: Bacterial meningitis

T. Wichelhaus, R. Nau, P. Shah, 2020, GMS infectious diseases.

Analysis of definitions used in clinical research on invasive fungal infections Consensus proposal for new, standardized definitions

D. Denning, J. Meis, J. Rex, 1999 .

Direct susceptibility testing of respiratory samples.

P. Shah, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Classification of oral cephalosporins.

P. Shah, 2002, International journal of antimicrobial agents.

Infectious Dermatoses, Venereology, Dermapathology

P. Shah, D. Hassler, 2010 .

The role of glycopeptide antibiotics in the treatment of infective endocarditis.

F. Antunes, D. Pittet, W. Graninger, 1999, International journal of antimicrobial agents.

Effect of aminoglycosides on proximal tubular membranes of the human kidney

W. Schoeppe, J. Scherberich, P. Shah, 1978, European Journal of Clinical Pharmacology.

Invasive pneumococcal disease in adults in North-Rhine Westphalia, Germany.

P. Shah, 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Pharmacokinetics and pharmacodynamics of fluoroquinolones.

O. Cars, G. Drusano, F. Sörgel, 1998, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Itraconazole for prophylaxis of systemic mycoses in neutropenic patients with haematological malignancies.

L. Bergmann, D. Hoelzer, A. Böhme, 1996, The Journal of antimicrobial chemotherapy.

The need for new therapeutic agents: what is the pipeline?

P. Shah, Pramod M. Shah, 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Influence of antimicrobial treatment on mortality in septicemia.

H. Brodt, G. Behrendt, P. Shah, 1999, Journal of chemotherapy.

Einfluss der verzögerten Transportdauer bei Raumtemperatur auf die Rate der falsch negativen Blutkulturen im BACTEC™ 9000 Gerät. Impact of delayed entry at room temperature on the rate of false negative blood cultures with the BACTEC™ 9000 instrument

U. Eigner, A. Fahr, P. Shah, 2005 .

Past and current roles for cephalosporin antibiotics in treatment of meningitis. Emphasis on use in gram-negative bacillary meningitis.

S. Landesman, M. Barza, C. Cherubin, 1981, The American journal of medicine.

In Vitro Activity of LY333328, a New Glycopeptide, against Extracellular and Intracellular Vancomycin-Resistant Enterococci

B. Al-Nawas, P. Shah, J. Swantes, 2000, Infection.

Surveillance of linezolid resistance in Germany, 2001-2002.

M. Kresken, D. Hafner, P. Shah, 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

D. Denning, J. Meis, D. Stevens, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Case Report. Successful therapy of disseminated histoplasmosis in AIDS with liposomal amphotericin B

E. Helm, P. Shah, G. Rieg, 1999, Mycoses.

Personalized antifungal susceptibility testing.

P. Shah, 1999, The Journal of antimicrobial chemotherapy.

In vitro activity of HR 756, a new cephalosporin compound.

G. Troché, P. Shah, W. Stille, 1978, The Journal of antibiotics.

Preventing post-treatment bacteremia: comparing topical povidone-iodine and chlorhexidine.

P. Shah, V. Schäfer, S. Schneider, 1995, Journal of the American Dental Association.

In vitro activity of norfloxacin in synthetic media and human urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid.

P. Shah, W. Stille, M. Ottnad-Walz, 1983, Methods and findings in experimental and clinical pharmacology.

Molecular Typing of Environmental and Patient Isolates of Aspergillus fumigatus from Various Hospital Settings

J. Latgé, E. Gluckman, G. Brücker, 1998, Journal of Clinical Microbiology.

Trends in the postmortem epidemiology of invasive fungal infections at a university hospital.

A. Groll, A H Groll, P M Shah, 1996, The Journal of infection.

[The evaluation of the Cand-Tec latex agglutination test (Ramco) in disseminated candidiasis].

P. Shah, H. Knothe, V. Schäfer, 2009, Mycoses.

Bactericidal activity of cefoxitin and cefuroxime.

H. Bender, P. Shah, 1978, The Journal of antimicrobial chemotherapy.

Cefpodoxime: Comparative antibacterial activity, influence of growth conditions, and bactericidal activity

P. Shah, H. Knothe, O. Eckardt, 1991, Infection.

Interaction Between Quinolones and Caffeine

A. Staib, S. Harder, P. Shah, 2012, Drugs.

Paradoxical effect of antibiotics. I. The 'Eagle effect'.

P. Shah, 1982, The Journal of antimicrobial chemotherapy.

Concentrations of piperacillin-tazobactam in human jaw and hip bone.

B. Al-Nawas, F. Soergel, P. Shah, 2008, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

Impact of oral ciprofloxacin on the faecal flora of healthy volunteers

P. Shah, R. Enzensberger, H. Knothe, 1985, Infection.

Impact of injectable cephalosporins on the gastrointestinal microflora: Observations in healthy volunteers and hospitalized patients

P. Shah, G. Dette, H. Knothe, 2005, Infection.

Influence of cefpirome on pharyngeal and faecal flora after single and multiple intravenous administrations of cefpirome to healthy volunteers.

P. Shah, H. Knothe, V. Schäfer, 1992, The Journal of antimicrobial chemotherapy.

Ciprofloxacin pharmacokinetics in patients with cystic fibrosis

A. Dalhoff, S. Bender, H. Posselt, 2005, Infection.

Decrease of caffeine elimination in man during co-administration of 4-quinolones.

A. Staib, S. Harder, P. Shah, 1987, The Journal of antimicrobial chemotherapy.

Evaluation of the OSIRIS video reader as an automated measurement system for the agar disk diffusion technique.

M Kolbert, F Chegrani, P M Shah, 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Kinetics of bacterial elimination in urine during antimicrobial treatment.

E. Helm, P. Shah, W. Stille, 1979, Journal of Antimicrobial Chemotherapy.

The effect of aminoglycosides on proximal tubular membranes of human kidneys

W. Schoeppe, J. Scherberich, P. Shah, 1979, Infection.

A randomized study of imipenem compared to cefotaxime plus piperacillin as initial therapy of infections in granulocytopenic patients

L. Bergmann, D. Hoelzer, A. Böhme, 1995, Infection.

Empirical antibacterial treatment for sepsis and the role of glycopeptides: recommendations from a European panel.

F. Antunes, D. Pittet, W. Graninger, 1997, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Activity of imipenem in an in-vitro model simulating pharmacokinetic parameters in human blood.

P. Shah, 1985, The Journal of antimicrobial chemotherapy.

Elimination of bacteria in biliary tract infections during ceftizoxime therapy

E. Helm, D. Wurbs, P. Shah, 2005, Infection.

Elimination of bacteria during antibacterial chemotherapy — a neglected parameter of chemotherapy

E. Helm, P. Shah, W. Stille, 2005, Infection.

Procalcitonin in patients with and without immunosuppression and sepsis

B. Al-Nawas, P. Shah, 1996, Infection.

Empirical monotherapy with meropenem versus imipenem/cilastatin for febrile episodes in neutropenic patients

Reiner Schaumann, A. Böhme, P. Shah, 1996, Infection.

Is TNF-α a prognostic factor in patients with sepsis?

Reiner Schaumann, P. Shah, M. Schaper, 1997 .

In-vitro activity of cefotetan, other β-lactams and netilmicin

P. Shah, 1983 .

Escherichia coli and Klebsiella pneumoniae strains more susceptible to cefoxitin than to third generation cephalosporins.

P. Shah, W. Stille, 1983, The Journal of antimicrobial chemotherapy.

Piperacillin/tazobactam versus cefepime as initial empirical antimicrobial therapy in febrile neutropenic patients: a prospective randomized pilot study.

D. Hoelzer, A. Böhme, P. Shah, 1998, European journal of medical research.

Cefotaxime versus ceftriaxone for the treatment of nosocomial pneumonia. Results of a multicenter study.

P. Shah, W. Stille, 1995, Diagnostic microbiology and infectious disease.

Safety profile of cefixime: Results of a german postmarketing surveillance study of 6361 patients

P. Shah, K. Tröster, 1994 .

Systemic treatment of septicaemia caused by P. aeruginosa with special reference to azlocillin.

P. Shah, 1984, Burns, including thermal injury.

Kalkulierte parenterale Initialtherapie bakterieller Infektionen: Bakterielle Endokarditis

W. Graninger, P. Dohmen, P. Shah, 2020 .

In vivo activity of cefodizime

P. Shah, H. Knothe, 2005, Infection.

In vitro activity of cefodizime

P. Shah, H. Knothe, 2005, Infection.

Influence of cefodizime on the reagibility of human leukocytes

M. Limbert, P. Shah, H. Muellner, 2005, Infection.

Cefodizime host-defence enhancement: Considerations of dose-response relationships in healthy volunteers

G. Gialdroni Grassi, P. Shah, 2005, Infection.

Comparison of BacT/Alert and BACTEC NR 860 blood culture systems in a laboratory not continuously staffed.

H. Linde, P. Shah, Gunther Riest, 1997, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Phagocytosis of E. Coli, K. Pneumoniae and S. Aureus by Human Granulocytes

C. Thomas, P. Shah, H. Rogge, 1987 .

Haemostasis during treatment with ciprofloxacin

M. Ziemen, K. Breddin, P. Shah, 2005, Infection.

Intracellular activity of vancomycin and Ly333328, a new semisynthetic glycopeptide, against methicillin-resistantStaphylococcus aureus

B. Al-Nawas, P. Shah, 1998, Infection.

[Clinical experience with a new cephalosporin derivative, Cefotaxim].

E. Helm, P. Shah, W. Stille, 1979, Die Medizinische Welt.

Simultaneous simulation of two different concentration time curves in vitro.

P. Shah, 1985, The Journal of antimicrobial chemotherapy.

Comparison of clinical response to cefpirome treatment and minimum inhibitory concentration of causative isolates. Microbiological and Clinical Study Groups.

M. Ziemen, P. Shah, V. Schäfer, 1992, The Journal of antimicrobial chemotherapy.

Susceptibility pattern of Streptococcus pneumoniae in outpatients in Germany.

P. Shah, S. Korn, E. Rosenthal, 2000, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[Life-threatening diarrhea in atypical course of legionellosis].

P. König, P. Shah, H. Schulte, 1993, Deutsche Medizinische Wochenschrift.

[Kinetics of the bactericidal effect of ampicillin, penicillin G, carbenicillin, cephalothin, kanamycin, gentamycin, polymyxin B and sulfamethoxazole-trimethoprim on Escherichia coli].

P. Shah, W. Stille, 1973, Arzneimittel-Forschung.

Activity of amikacin at sub-inhibitory levels.

P. Shah, W. Stille, G. Heetderks, 1976, Journal of Antimicrobial Chemotherapy.

Intracellular activity of ciprofloxacin and moxifloxacin, a new 8-methoxyquinolone, against methicillin-resistant Staphylococcus aureus.

B. Al-Nawas, P. Shah, B. Al‐Nawas, 1998, The Journal of antimicrobial chemotherapy.

The in vitro activity of flomoxef compared to four other cephalosporins and imipenem

P. Shah, H. Knothe, 2005, Infection.

Clinical Experience with Cefotaxime in Internal Medicine between 1981 and 1984

P. Shah, W. Stille, M. Wiesel, 2012, Drugs.

Medical and veterinary use of antimicrobial agents: implications for public health. A clinician's view on antimicrobial resistance.

P. Shah, H. Knothe, V. Schäfer, 1993, Veterinary microbiology.

Invasive mycosis in post-mortem findings

K. Hübner, G. Just, A. Groll, 1994 .

[S2 guideline for infectious endocarditis].

R. Erbel, M. Block, K. Werdan, 2004, MMW Fortschritte der Medizin.

Parenteral carbapenems.

P. Shah, 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Clinical experience with imipenem/cilastatin: analysis of a multicenter study.

P. Shah, 1985, Reviews of infectious diseases.